SeaStar Medical Holding Corp
ICU0.305USD
-0.005-1.61%
Close 11/21, 16:00（ET）Quotes delayed by 15 min
10.40MMarket Cap
LossP/E TTM
More Details of SeaStar Medical Holding Corp Company
SeaStar Medical Holding Corporation is a commercial-stage medical technology company. The Company is focused on developing extracorporeal therapies to reduce the consequences of hyperinflammation on vital organs. The Company's technologies rely on science to provide life-saving solutions to critically ill patients. The Company develops and commercializes cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company uses its Selective Cytopheretic Device (SCD) technology platform to clinically validate several acute organ injury indications, including kidneys and lungs. Its investigational SCD is an extracorporeal synthetic membrane device designed to integrate into existing continuous renal replacement therapy (CRRT) systems that are commonly installed in hospitals throughout the United States.
SeaStar Medical Holding Corp Info
Ticker SymbolICU
Company nameSeaStar Medical Holding Corp
IPO dateJan 26, 2021
CEOMr. Eric Schlorff
Number of employees19
Security typeOrdinary Share
Fiscal year-endJan 26
Address3513 Brighton Blvd
CityDENVER
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code80216
Phone18444278100
Websitehttps://seastarmedical.com
Ticker SymbolICU
IPO dateJan 26, 2021
CEOMr. Eric Schlorff
Company Executives of SeaStar Medical Holding Corp
Name
Name/Position
Position
Shareholding
Change
Mr. John Neuman
Mr. John Neuman
Independent Director
Independent Director
82.67K
--
Mr. Eric Schlorff
Mr. Eric Schlorff
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
55.18K
--
Dr. Kevin Chung, M.D.
Dr. Kevin Chung, M.D.
Chief Medical Officer
Chief Medical Officer
33.18K
--
Ms. Jennifer A. (Jen) Baird
Ms. Jennifer A. (Jen) Baird
Independent Chairman of the Board
Independent Chairman of the Board
22.67K
--
Ms. Bernadette N. Vincent
Ms. Bernadette N. Vincent
Independent Director
Independent Director
2.67K
--
Mr. Kenneth (Ken) Van Heel
Mr. Kenneth (Ken) Van Heel
Independent Director
Independent Director
--
--
Mr. Michael Hollan Messinger, CPA
Mr. Michael Hollan Messinger, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. John Neuman
Mr. John Neuman
Independent Director
Independent Director
82.67K
--
Mr. Eric Schlorff
Mr. Eric Schlorff
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
55.18K
--
Dr. Kevin Chung, M.D.
Dr. Kevin Chung, M.D.
Chief Medical Officer
Chief Medical Officer
33.18K
--
Ms. Jennifer A. (Jen) Baird
Ms. Jennifer A. (Jen) Baird
Independent Chairman of the Board
Independent Chairman of the Board
22.67K
--
Ms. Bernadette N. Vincent
Ms. Bernadette N. Vincent
Independent Director
Independent Director
2.67K
--
Mr. Kenneth (Ken) Van Heel
Mr. Kenneth (Ken) Van Heel
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Nov 19
Updated: Wed, Nov 19
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
1.05%
Geode Capital Management, L.L.C.
0.72%
Millennium Management LLC
0.50%
Neuman (John)
0.23%
Schlorff (Eric)
0.15%
Other
97.35%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
1.05%
Geode Capital Management, L.L.C.
0.72%
Millennium Management LLC
0.50%
Neuman (John)
0.23%
Schlorff (Eric)
0.15%
Other
97.35%
Shareholder Types
Shareholders
Proportion
Investment Advisor
1.49%
Investment Advisor/Hedge Fund
0.75%
Individual Investor
0.74%
Hedge Fund
0.50%
Research Firm
0.14%
Venture Capital
0.13%
Bank and Trust
0.01%
Other
96.23%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
56
847.20K
2.48%
-188.93K
2025Q2
64
1.04M
4.18%
+532.11K
2025Q1
64
1.12M
9.53%
+609.78K
2024Q4
56
403.35K
5.53%
-59.49K
2024Q3
101
532.19K
15.84%
-408.40K
2024Q2
105
549.58K
17.81%
-317.45K
2024Q1
106
490.37K
46.99%
-245.21K
2023Q4
100
525.53K
64.26%
-360.30K
2023Q3
92
529.03K
69.17%
-298.51K
2023Q2
88
487.42K
67.26%
-347.45K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
57.50K
0.21%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
68.83K
0.25%
-5.81K
-7.79%
Jun 30, 2025
Neuman (John)
82.67K
0.3%
-1.33K
-1.59%
Aug 05, 2025
Schlorff (Eric)
55.18K
0.2%
--
--
Aug 05, 2025
Trinity Financial Advisors LLC
50.00K
0.18%
+35.00K
+233.33%
Sep 30, 2025
XTX Markets LLC
60.98K
0.22%
+48.67K
+395.43%
Jun 30, 2025
Van Heel (Kenneth J.)
45.08K
0.16%
+34.70K
+334.30%
Aug 27, 2025
Chung (Kevin)
33.18K
0.12%
+10.00K
+43.13%
Aug 22, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jun 06, 2024
Merger
25→1
Jun 06, 2024
Merger
25→1
Jun 06, 2024
Merger
25→1
Jun 06, 2024
Merger
25→1
Date
Type
Ratio
Jun 06, 2024
Merger
25→1
Jun 06, 2024
Merger
25→1
Jun 06, 2024
Merger
25→1
Jun 06, 2024
Merger
25→1
FAQs
Who are the top five shareholders of SeaStar Medical Holding Corp?
The top five shareholders of SeaStar Medical Holding Corp are:
The Vanguard Group, Inc. holds 57.50K shares, accounting for 0.21% of the total shares.
Geode Capital Management, L.L.C. holds 68.83K shares, accounting for 0.25% of the total shares.
Neuman (John) holds 82.67K shares, accounting for 0.30% of the total shares.
Schlorff (Eric) holds 55.18K shares, accounting for 0.20% of the total shares.
Trinity Financial Advisors LLC holds 50.00K shares, accounting for 0.18% of the total shares.
The Vanguard Group, Inc. holds 57.50K shares, accounting for 0.21% of the total shares.
Geode Capital Management, L.L.C. holds 68.83K shares, accounting for 0.25% of the total shares.
Neuman (John) holds 82.67K shares, accounting for 0.30% of the total shares.
Schlorff (Eric) holds 55.18K shares, accounting for 0.20% of the total shares.
Trinity Financial Advisors LLC holds 50.00K shares, accounting for 0.18% of the total shares.
What are the top three shareholder types of SeaStar Medical Holding Corp?
The top three shareholder types of SeaStar Medical Holding Corp are:
The Vanguard Group, Inc.
Geode Capital Management, L.L.C.
Millennium Management LLC
The Vanguard Group, Inc.
Geode Capital Management, L.L.C.
Millennium Management LLC
How many institutions hold shares of SeaStar Medical Holding Corp (ICU)?
As of 2025Q3, 56 institutions hold shares of SeaStar Medical Holding Corp, with a combined market value of approximately 847.20K, accounting for 2.48% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -1.70%.
What is the biggest source of revenue for SeaStar Medical Holding Corp?
In --, the -- business generated the highest revenue for SeaStar Medical Holding Corp, amounting to -- and accounting for --% of total revenue.
